Project Search Results

Select

Research Categorization

Operator
Operator

Project Details

Operator
Operator

Contact Researcher and Awardee Organization

Operator
Operator

Funding Organization

Operator
Operator
Operator
Operator
ListGraphMap
Displaying 11 - 20 of 436 Projects
Project # Contact PI Funding Organization Fiscal Year
A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 1b/2a Study of WVE-004 Administered Intrathecally to Patients with C9orf72-associated Amyotrophic Lateral Sclerosis (ALS) or Frontotemporal Dementia (FTD)
ADDF-35 Panzara, Michael Alzheimer's Drug Discovery Foundation 2021
Plasma pathologic TDP-43 as a biomarker for FTLD-TDP
ADDF-36 Mao, Qinwen Alzheimer's Drug Discovery Foundation 2021
Can Lifestyle Changes Stop or Reverse the Progression of MCI Due to Early-Stage Alzheimer's Disease?
ADDF-37 Ornish, Dean Alzheimer's Drug Discovery Foundation 2021
Easy and early plasma pTau181 detection with LUMIPULSE G platform as indicator of Alzheimer's disease
ADDF-38 Vandijck, Manu Alzheimer's Drug Discovery Foundation 2021
Effects of Chaperone-Mediated Autophagy in Alzheimer's Disease
ADDF-39 Cermak, Jennifer Alzheimer's Drug Discovery Foundation 2021
Clinical Trials for Alzheimer's Disease CTAD
ADDF-40 Touchon, Nathanaelle Alzheimer's Drug Discovery Foundation 2021
Validation and commercialization of a novel blood-based, ultra-multiplex Laboratory Developed Test (LDT) for the prediction of cerebral amyloid status before clinical onset of dementia
ADDF-41 Anderson, Leyla Alzheimer's Drug Discovery Foundation 2021
Plasma neuroinflammatory biomarkers for the diagnossi of dementia subtypes
ADDF-42 Pase, Matthew Alzheimer's Drug Discovery Foundation 2021
MIB-626 For Treatment of Mild Dementia Patients
ADDF-43 Livingston, David Alzheimer's Drug Discovery Foundation 2021
Fixational eye motion as biomarker for mild cognitive impairment
ADDF-45 Sheehy, Christy Alzheimer's Drug Discovery Foundation 2021